LUNAC Therapeutics Wins Start Up of the Year at Bionow Awards
Leeds, UK, 5 February 2021: LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the development of advanced life-saving anticoagulants, has been named as this year’s Start Up of the Year winner at the 19th Bionow Awards.
The 19th Bionow Awards took place with an online ceremony on Thursday 4 February 2021 and showcased the best of this world-class sector. The Start Up Award recognised organisations that are using innovative approaches to solve a significant healthcare need, and where the company has a high-growth potential.
Bionow is a not-for-profit membership organisation supporting the biomedical, pharma and life sciences sectors across the North of England. The awards bring together leaders in the North of England’s life sciences industry and recognises life sciences companies, academics and health organisations for their application of cutting-edge technologies.
Dr Mervyn Turner, Chair of LUNAC Therapeutics, said:
“LUNAC is honoured to receive the Bionow Start Up of the Year award and the recognition of our peers throughout the UK and further afield. LUNAC has leading scientific founders, supported by a quality network of UK partners. We look forward to building our team and growing LUNAC as we make progress on this important antithrombosis project.”